[1] Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015[J]. CA: A Cancer Journal for Clinicians, 2016, 66(2).
[2] Siegel R L, Miller K D, Jemal A. Cancer statistics, 2020[J]. CA: A Cancer Journal for Clinicians, 2020, 70(1).
[3] Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. (2004) 363:1049–57
[4] Gu X, Zhou R, Li C, et al. Preoperative maximum standardized uptake value and carbohydrate antigen 19–9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma[J]. BMC Cancer, 2019, 19.
[5] Chang Z W, Dong L, Qin Y R, et al. Correlations between gastric cancer family history and ROBO2 and RASSF2A gene methylations. [J]. Journal of Cancer Research and Therapeutics, 2016, 12(2):597.
[6] Aleksandra, Gołos, Dorota, et al. The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia. [J]. Archivum immunologiae et therapiae experimentalis, 2019.
[7] Je E M, Gwak M, Oh H, et al. Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability. [J]. Pathology, 2013, 45(7):645.
[8] Choi Y J, Yoo N J, Lee S H. Down-regulation of ROBO2 Expression in Prostate Cancers[J]. Pathology & Oncology Research, 2013.
[9] Dickinson, Rachel, E, et al. Glucocorticoid Regulation of SLIT/ROBO Tumour Suppressor Genes in the Ovarian Surface Epithelium and Ovarian Cancer Cells. [J]. Plos One, 2011.
[10] Anil, Prasad, Aaron, et al. Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells[J]. Journal of Biological Chemistry, 2003.
[11] lu J, Zhou L, You L, et al. Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma[J]. Human Pathology, 2019, 86:143-154.
[12] Nguyen-Ba-Charvet KT, Chédotal A. Role of Slit proteins in the vertebrate brain. J Physiol Paris. 2002 Jan-Mar;96(1-2):91-8.
[13] Gröne J, Doebler O, Loddenkemper C, Hotz B, Buhr HJ, Bhargava S. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. Oncol Rep. 2006 Jun;15(6):1437-43.
[14] Schmid BC, Rezniczek GA, Fabjani G, Yoneda T, Leodolter S, Zeillinger R. The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells. Breast Cancer Res Treat. 2007 Dec;106(3):333-42.
[15] Huang Z, Wen P, Kong R, Cheng H, Zhang B, Quan C, Bian Z, Chen M, Zhang Z, Chen X, Du X, Liu J, Zhu L, Fushimi K, Hua D, Wu JY. USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration. Int J Cancer. 2015 Apr 15;136(8):1792-802.
[16] Stella MC, Trusolino L, Comoglio PM. The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. Mol Biol Cell. 2009 Jan;20(2):642-57.
[17] Wen P, Kong R, Liu J, Zhu L, Chen X, Li X, Nie Y, Wu K, Wu JY. USP33, a new player in lung cancer, mediates Slit-Robo signaling. Protein Cell. 2014 Sep;5(9):704-13.
[18] Gonçalves AN, Correia-Pinto J, Nogueira-Silva C. ROBO2 signaling in lung development regulates SOX2/SOX9 balance, branching morphogenesis and is dysregulated in nitrofen-induced congenital diaphragmatic hernia. Respir Res. 2020 Nov 18;21(1):302.
[19] S. Escot, D. Willnow, H. Naumann et al.., “Robo signalling controls pancreatic progenitor identity by regulating tead transcription factors,” Nature Communications, vol. 9, no. 1, 2018.
[20] Skuja E, Butane D, Nakazawa-Miklasevica M, Daneberga Z, Purkalne G, Miklasevics E. Deletions in metastatic colorectal cancer with chromothripsis. Exp Oncol. 2019 Dec;41(4):323-327.
[21] Solyom S, Ewing AD, Rahrmann EP, Doucet T, Nelson HH, Burns MB, Harris RS, Sigmon DF, Casella A, Erlanger B, Wheelan S, Upton KR, Shukla R, Faulkner GJ, Largaespada DA, Kazazian HH Jr. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012 Dec;22(12):2328-38.
[22] Biankin AV, Waddell N, Kassahn KS et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012 Nov 15;491(7424):399-405.
[23] Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015 Feb 26;518(7540):495-501.
[24] Achyut BR, Yang L. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011 Oct;141(4):1167-78.
[25] Pinho AV, Van Bulck M, Chantrill L, et al. ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. Nat Commun. 2018 Nov 30;9(1):5083.
[26] Han S, Cao C, Tang T, Lu C, Xu J, Wang S, Xue L, Zhang X, Li M. ROBO3 promotes growth and metastasis of pancreatic carcinoma. Cancer Lett. 2015 Sep 28;366(1):61-70.
[27] Gan L, Meng J, Xu M, Liu M, Qi Y, Tan C, Wang Y, Zhang P, Weng W, Sheng W, Huang M, Wang Z. Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer. Oncogene. 2018 Feb 8;37(6):744-755.
[28] Lal G, Hashimi S, Smith BJ, Lynch CF, Zhang L, Robinson RA, Weigel RJ. Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa. Ann Surg Oncol. 2009 Aug;16(8):2280-7.
[29] Gu M, Guan J, Zhao L, Ni K, Li X, Han Z. Correlation of ECM1 expression level with the pathogenesis and metastasis of laryngeal carcinoma. Int J Clin Exp Pathol. 2013 May 15;6(6):1132-7.
[30] Chen H, Jia WD, Li JS, Wang W, Xu GL, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB, Zhang CH, Wang YC. Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Med Oncol. 2011 Dec;28 Suppl 1: S318-25.
[31] Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol. 2007;39(12):2153-60.
[32] Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005 Jul 15;65(14):5991-5;
[33] Chen HT, Liu H, Mao MJ, Tan Y, Mo XQ, Meng XJ, Cao MT, Zhong CY, Liu Y, Shan H, Jiang GM. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer. 2019 May 24;18(1):101.
[34] Chang CJ, Chao CH, Xia W, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol. 2011 Mar;13(3):317-23.
[35] Chang CJ, Chao CH, Xia W, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol. 2011 Mar;13(3):317-23.
[36] Lee KM, Nam K, Oh S, et al. ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin. Oncogene. 2015 Dec 10;34(50):6055-65.
[37] Wu Q, Chen D, Luo Q, Yang Q, Zhao C, Zhang D, Zeng Y, Huang L, Zhang Z, Qi Z. Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis. Cancer Lett. 2018 Nov 28;437:44-55.
[38] Park J, Kim DH, Shah SR, Kim HN, Kshitiz, Kim P, Quiñones-Hinojosa A, Levchenko A. Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases. Nat Commun. 2019 Jun 26;10(1):2797.